Leukemias and plasma cell dyscrasias

作者: Peter H. Wiernik

DOI: 10.1016/J.UCT.2007.07.002

关键词:

摘要: Abstract This review details major new observations in the diagnosis and treatment of leukemias plasma cell dyscrasias that have been communicated since last version this work. is not exhaustive may appear to some be rather superficial. However, it should serve as an accurate index current thinking accomplishments. The clearly demonstrates a trend away from traditional chemotherapeutic approaches related diseases favor more rational design treatments for specific based on laboratory observations. Some refer agents resulted such approach targeted therapy suggest they represent era cancer treatment, although one first conceived, synthesized tested was 6-mercaptopurine decades ago. Furthermore, there no than surgery, which has practiced longer any us lived. At rate, whatever slogan used describe clear preclinical science ever before. chapter certainly true dyscrasias. What demonstrated yet better rationale led results. That remains proven or disproven by continued observation our treated patients.

参考文章(247)
Ola Landgren, Joshua S. Rapkin, Neil E. Caporaso, Lene Mellemkjaer, Gloria Gridley, Lynn R. Goldin, Eric A. Engels, Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood. ,vol. 109, pp. 2198- 2201 ,(2007) , 10.1182/BLOOD-2006-08-044008
Silke Meister, Ulrich Schubert, Kirsten Neubert, Kai Herrmann, Renate Burger, Martin Gramatzki, Sabine Hahn, Sandra Schreiber, Sabine Wilhelm, Martin Herrmann, Hans-Martin Jäck, Reinhard E. Voll, Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Cancer Research. ,vol. 67, pp. 1783- 1792 ,(2007) , 10.1158/0008-5472.CAN-06-2258
David Ng, Ousmane Toure, Ming-Hui Wei, Diane C. Arthur, Fatima Abbasi, Laura Fontaine, Gerald E. Marti, Joseph F. Fraumeni, Lynn R. Goldin, Neil Caporaso, Jorge R. Toro, Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia Blood. ,vol. 109, pp. 916- 925 ,(2007) , 10.1182/BLOOD-2006-03-011825
Adrian Duek, Edith Feldberg, Michal Haran, Alain Berrebi, Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug American Journal of Hematology. ,vol. 82, pp. 502- 503 ,(2007) , 10.1002/AJH.20891
Mary L. McMaster, Lynn R. Goldin, Yan Bai, Monica Ter-Minassian, Stefan Boehringer, Therese R. Giambarresi, Linda G. Vasquez, Margaret A. Tucker, Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families. American Journal of Human Genetics. ,vol. 79, pp. 695- 701 ,(2006) , 10.1086/507687
Martin Benesch, Petra Sovinz, Barbara Krammer, Herwig Lackner, Georg Mann, Wolfgang Schwinger, Helmut Gadner, Christian Urban, Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis. Journal of Pediatric Hematology Oncology. ,vol. 29, pp. 222- 226 ,(2007) , 10.1097/MPH.0B013E318041F112
Riccardo Bomben, Michele Dal Bo, Daniela Capello, Dania Benedetti, Daniela Marconi, Antonella Zucchetto, Francesco Forconi, Rossana Maffei, Emanuela M. Ghia, Luca Laurenti, Pietro Bulian, Maria Ilaria Del Principe, Giuseppe Palermo, Mia Thorsélius, Massimo Degan, Renato Campanini, Anna Guarini, Giovanni Del Poeta, Richard Rosenquist, Dimitar G. Efremov, Roberto Marasca, Robin Foà, Gianluca Gaidano, Valter Gattei, Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study Blood. ,vol. 109, pp. 2989- 2998 ,(2007) , 10.1182/BLOOD-2006-10-051110
Linda M. Scott, Wei Tong, Ross L. Levine, Mike A. Scott, Philip A. Beer, Michael R. Stratton, P. Andrew Futreal, Wendy N. Erber, Mary Frances McMullin, Claire N. Harrison, Alan J. Warren, D. Gary Gilliland, Harvey F. Lodish, Anthony R. Green, JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis The New England Journal of Medicine. ,vol. 356, pp. 459- 468 ,(2007) , 10.1056/NEJMOA065202
Hiroshi Yasui, Teru Hideshima, Hiroshi Ikeda, Janice Jin, Enrique M. Ocio, Tanyel Kiziltepe, Yutaka Okawa, Sonia Vallet, Klaus Podar, Kenji Ishitsuka, Paul G. Richardson, Chris Pargellis, Neil Moss, Noopur Raje, Kenneth C. Anderson, BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth. British Journal of Haematology. ,vol. 136, pp. 414- 423 ,(2007) , 10.1111/J.1365-2141.2006.06443.X
J. Styczynski, Drug resistance in childhood acute myeloid leukemia. Current Pharmaceutical Biotechnology. ,vol. 8, pp. 59- 75 ,(2007) , 10.2174/138920107780487465